GeoVax raises ~$863k via warrant exercise inducement, issues new warrants for 1.27M shares

GeoVax Labs, Inc.

Existing warrant holders exercise 634,658 shares at reduced $1.36/share, gross proceeds ~$863k.
GeoVax issues new warrants to purchase up to 1,269,316 shares at $1.36, exercisable after stockholder approval.
Net proceeds to be used for working capital and general corporate purposes.
Closing expected April 1, 2026; A.G.P./Alliance Global Partners receives 7% cash fee.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

GeoVax Labs, Inc. issued an aggregate of up to 1,269,316 shares of the Company's common stock of warrant to Holders of Existing Warrants for exercise of Existing Warrants for cash at $1.36 per share, aggregate gross proceeds of approximately $863,000.

Security: warrant
Shares: an aggregate of up to 1,269,316 shares of the Company's common stock
Purchaser: Holders of Existing Warrants
Consideration: exercise of Existing Warrants for cash at $1.36 per share, aggregate gross proceeds of approximately $863,000

Exact text from the filing

which the Holders agreed to exercise for cash their Existing Warrants to purchase an aggregate of 634,658 shares of the Company’s common stock, at a reduced exercised price of $1.36 per share, in consideration for the Company’s agreement to issue new warrants (the “New Warrants”) to purchase an aggregate of up to 1,269,316 shares of the Company’s common stock

View on SEC.gov

Browse all equity issuances →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-010733

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.